Aardvark Therapeutics Registration Statement Effective
Ticker: AARD · Form: EFFECT · Filed: 2026-04-06T00:15:13-04:00
Sentiment: neutral
Topics: registration-statement, effectiveness
TL;DR
Aardvark Therapeutics registration statement is now effective as of 4/3/2026.
AI Summary
Aardvark Therapeutics, Inc. (CIK: 0001774857) filed an EFFECT form, indicating the effectiveness of a registration statement, on April 6, 2026. The effectiveness date is noted as April 3, 2026. The company is located at 4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122.
Why It Matters
This filing signifies that Aardvark Therapeutics' registration statement has been declared effective by the SEC, allowing for the potential sale of securities.
Risk Assessment
Risk Level: medium — The effectiveness of a registration statement is a procedural step that can precede significant financial events, carrying inherent market risks.
Key Numbers
- 333-294537 — File Number (SEC registration file number)
Key Players & Entities
- Aardvark Therapeutics, Inc. (company) — Filer
- 0001774857 (company) — CIK
- 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (address) — Mailing and Business Address
- 2026-04-06 (date) — Acceptance Date
- 2026-04-03 (date) — Effectiveness Date
FAQ
What type of filing is this?
This is an EFFECT filing, which signifies the effectiveness of a registration statement.
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-06.
What is the effectiveness date of the registration statement?
The effectiveness date is 2026-04-03.
What is the CIK number for Aardvark Therapeutics, Inc.?
The CIK number for Aardvark Therapeutics, Inc. is 0001774857.
What is the business address of Aardvark Therapeutics, Inc.?
The business address is 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122.
From the Filing
EDGAR Filing Documents for 9999999995-26-001083 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001083 Accepted 2026-04-06 00:15:13 Documents 1 Effectiveness Date 2026-04-03 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 597 Complete submission text file 9999999995-26-001083.txt 1783 Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696 Aardvark Therapeutics, Inc. (Filer) CIK : 0001774857 (see all company filings) EIN. : 821606367 | State of Incorp.: DE | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-294537 | Film No.: 26839466 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)